BCT
vs
S
S&P/ASX 300
BCT
Over the past 12 months, BCT has underperformed S&P/ASX 300, delivering a return of 0% compared to the S&P/ASX 300's +5% growth.
Stocks Performance
BCT vs S&P/ASX 300
Performance Gap
BCT vs S&P/ASX 300
Performance By Year
BCT vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Bluechiip Ltd
Glance View
Bluechiip Ltd. engages in the development of information technology-based temperature and identification tracking solution for biosamples in the health and life sciences industry. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-06-09. The firm offers technical capabilities over handwritten and printed labels, barcodes and radio frequency identification (RFID) technologies. Its products include Bluechiip Enabled Vial Range, Bluechiip Universal CryoBox, Bluechiip CryoTag Range, Bluechiip BoxTracker, Bluechiip MultiVial Reader, Bluechiip Handheld Reader, Stream 5 Sample Management Software, Bluechiip Ready CryoCassettes, and Bluechiip Ready Towers and Frames. Its intellectual property (IP) portfolio includes 24 granted patents in seven families, including the core micro electro mechanical system (MEMS) memory device and sample storage. The company also monitors systems that include sample level identification (ID) and temperature tracking.
